Scienture Holdings (SCNX) Non-Current Debt (2016 - 2026)
Scienture Holdings' (SCNX) quarterly Non-Current Debt came in at $9.6 million in Q2 2026, up 378.43% year-over-year from $2.0 million in Q2 2025, and up 20862.59% quarter-over-quarter from $45646.0 in Q4 2025.
Analysis
Scienture Holdings (SCNX) Non-Current Debt (2016 - 2026) Analysis & Trends
Scienture Holdings has disclosed Non-Current Debt across 10 years of filings, most recently posting $9.6 million for Q2 2026.
- In Q2 2026, Non-Current Debt rose 378.43% year-over-year to $9.6 million; the TTM figure through Jun 2026 stood at $9.6 million (up 378.43% YoY), while the FY2025 annual figure was $45646.0, down 97.72% from the prior year.
- Non-Current Debt came in at $9.6 million for Q2 2026 at Scienture Holdings, up from $45646.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $9.6 million in Q2 2026 to a low of $45646.0 in Q4 2025.
- Average Non-Current Debt over 5 years is $2.5 million, with a median of $2.0 million recorded in 2024.
- Year-over-year, Non-Current Debt surged 1866.5% in 2023 and sank 97.72% in 2025.
- Over 5 years, Non-Current Debt stood at $333333.0 in 2022, then surged by 1866.5% to $6.6 million in 2023, then slumped by 69.49% to $2.0 million in 2024, then slumped by 97.72% to $45646.0 in 2025, then jumped by 20862.59% to $9.6 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $9.6 million in Q2 2026, $45646.0 in Q4 2025, and $2.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 12.09 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 11.61 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 150.67 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 2.57 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 20.74 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 280.16 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.26 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 609.56 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 9.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.57 Mn |
| Dec 31, 2025 | 45,646.00 |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Dec 31, 2023 | 6.56 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Dec 31, 2022 | 333,333.00 |
| Sep 30, 2022 | 333,333.00 |
| Jun 30, 2022 | 333,333.00 |
| Mar 31, 2022 | 333,333.00 |
| Sep 30, 2020 | 225,000.00 |
| Jun 30, 2020 | 225,000.00 |
| Mar 31, 2020 | 225,000.00 |
| Dec 31, 2019 | 225,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 522,552.00 |
| Mar 31, 2019 | 522,552.00 |